Credit Suisse’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.37M | Buy |
319,592
+6,046
| +2% | +$63.7K | ﹤0.01% | 1524 |
|
|
2023
Q4 | $3.52M | Buy |
313,546
+44,083
| +16% | +$495K | ﹤0.01% | 1532 |
|
|
2023
Q3 | $3.15M | Sell |
269,463
-113,650
| -30% | -$1.33M | ﹤0.01% | 1542 |
|
|
2023
Q2 | $3.86M | Buy |
383,113
+113,633
| +42% | +$1.15M | ﹤0.01% | 1490 |
|
|
2023
Q1 | $1.99M | Buy |
269,480
+18,976
| +8% | +$140K | ﹤0.01% | 1856 |
|
|
2022
Q4 | $2M | Buy |
250,504
+37,644
| +18% | +$301K | ﹤0.01% | 1864 |
|
|
2022
Q3 | $685K | Sell |
212,860
-41,255
| -16% | -$133K | ﹤0.01% | 2579 |
|
|
2022
Q2 | $1.03M | Buy |
254,115
+201,573
| +384% | +$820K | ﹤0.01% | 2337 |
|
|
2022
Q1 | $260K | Hold |
52,542
| – | – | ﹤0.01% | 3263 |
|
|
2021
Q4 | $530K | Buy |
+52,542
| New | +$530K | ﹤0.01% | 2981 |
|